These data indicated that following myocardial ischemia–reperfusion treatment, impairment of the NRF2/FPN1 signaling pathway caused development of ferroptosis to exacerbate the myocardial IRI, in diabetic rats compared with that in non-diabetic rats. Here, SLC40A1 is linked to myocardial ischemia.